Anemia is one of the most frequent complications of chronic kidney disease (CKD), affecting a significant percentage of individuals as kidney function declines. For patients in Berwyn and North Chicago, Illinois, as well as Bergen, New Jersey, understanding the link between kidney disease and anemia can help explain symptoms such as fatigue, weakness, and shortness of breath that may otherwise seem unrelated. For residents of Berwyn, North Chicago, and Bergen, Nephrology Associates of Northern Illinois and Indiana (NANI) continues to provide education that helps patients understand the broader effects of kidney disease, including anemia.
While anemia can develop for many reasons, its presence in CKD is closely tied to how the kidneys function beyond waste filtration. Healthy kidneys do more than remove toxins—they also help regulate hormones that influence red blood cell production. When kidney function declines, this hormonal balance is disrupted, increasing the likelihood of anemia. Recognizing this connection helps patients understand why anemia is so common in CKD and why monitoring is essential.
The Kidney’s Role in Red Blood Cell Production
The kidneys produce a hormone called erythropoietin (EPO), which signals the bone marrow to create red blood cells. Red blood cells are responsible for carrying oxygen from the lungs to tissues throughout the body. When oxygen delivery is adequate, organs and muscles function efficiently.
In chronic kidney disease, damaged kidneys produce less erythropoietin. Without sufficient EPO, the bone marrow does not receive the signal to generate enough red blood cells. As a result, red blood cell counts decline, and anemia develops.
Understanding how kidney disease affects multiple systems can be reinforced through kidney disease information, which explains how declining filtration and hormonal changes contribute to broader health effects beyond waste removal.
The decline in erythropoietin production often begins in moderate stages of CKD and becomes more pronounced as kidney function worsens. Because this process is gradual, anemia may develop slowly, making it harder for individuals to recognize early symptoms.
Symptoms of Anemia in Kidney Disease
Anemia in CKD often presents with subtle but persistent symptoms. Fatigue is the most common complaint. Individuals may feel unusually tired despite adequate sleep, or they may notice decreased stamina during everyday activities. This fatigue occurs because tissues are receiving less oxygen due to lower red blood cell counts.
Other common symptoms include shortness of breath during exertion, dizziness, pale skin, cold intolerance, headaches, and difficulty concentrating. In more advanced cases, anemia can place extra strain on the heart, leading to chest discomfort or palpitations.
Because these symptoms overlap with other chronic conditions—such as heart disease or aging—anemia may be overlooked without laboratory testing. Learning how kidney function is measured and monitored can help individuals connect these symptoms with possible kidney-related causes. Educational resources, such as kidney function education, provide insight into how blood tests reflect kidney health and related complications.
Additional Factors That Contribute to Anemia in CKD
Reduced erythropoietin production is the primary driver of anemia in CKD, but it is not the only factor. Individuals with kidney disease may also experience iron deficiency, either due to reduced dietary intake, impaired absorption, or blood loss. Iron is essential for producing hemoglobin, the oxygen-carrying component of red blood cells. Without adequate iron, even sufficient erythropoietin cannot fully correct anemia.
Chronic inflammation, which is common in kidney disease, may further suppress red blood cell production. Inflammatory markers can interfere with iron utilization and shorten the lifespan of red blood cells. Additionally, certain medications and frequent blood testing in advanced kidney disease may contribute to lower red blood cell counts.
Fluid retention, another common feature of CKD, can dilute red blood cell concentration in the bloodstream, making anemia appear more pronounced on laboratory testing.
These overlapping factors demonstrate why anemia in kidney disease often requires a comprehensive evaluation rather than a single test result.
Risks of Untreated Anemia in Kidney Disease
When anemia remains untreated, the body must compensate for reduced oxygen delivery. The heart works harder to circulate blood, which may increase the risk of left ventricular hypertrophy and other cardiovascular complications. Over time, this added strain can worsen existing heart conditions or contribute to new ones.
Anemia can also affect cognitive function, mood, and overall quality of life. Persistent fatigue may limit physical activity, which in turn impacts cardiovascular health and muscle strength. For older adults, untreated anemia may increase the risk of falls or functional decline.
Recognizing and addressing anemia early helps reduce these risks. Routine blood testing as part of CKD monitoring allows providers to detect declining hemoglobin levels before symptoms become severe.
How Anemia in CKD Is Evaluated
Evaluation typically begins with a complete blood count (CBC) to measure hemoglobin and hematocrit levels. Additional tests assess iron levels, ferritin, transferrin saturation, and vitamin B12 and folate status. These measurements help determine whether anemia is primarily due to reduced erythropoietin, iron deficiency, or a combination of factors.
Providers may also review kidney function trends, including estimated glomerular filtration rate (eGFR), to assess how declining filtration correlates with anemia severity. Monitoring trends over time is particularly important, as gradual changes may reveal patterns that guide treatment decisions.
Individuals interested in broader kidney protection strategies can explore kidney protection resources to understand how managing blood pressure, blood sugar, and lifestyle habits may help slow CKD progression and reduce complications such as anemia.
Treatment Options for Kidney-Related Anemia
Treatment depends on the underlying cause and severity of anemia. Iron supplementation—either oral or intravenous—may be recommended when iron deficiency is present. Correcting iron levels can improve hemoglobin production and overall energy levels.
For individuals with significant erythropoietin deficiency, erythropoiesis-stimulating agents (ESAs) may be used to encourage red blood cell production. These medications mimic the action of natural erythropoietin and help increase hemoglobin levels gradually.
Treatment is carefully monitored to avoid excessive increases in hemoglobin, which can carry cardiovascular risks. The goal is not to normalize hemoglobin completely but to reach a safe range that improves symptoms and reduces complications.
In advanced kidney disease or dialysis patients, anemia management becomes an ongoing component of care. Regular laboratory testing ensures that iron levels and hemoglobin remain within appropriate ranges.
Supporting Long-Term Wellness With Early Awareness
Anemia is a common and manageable complication of chronic kidney disease. Understanding why it occurs empowers patients to recognize symptoms early and participate actively in monitoring and treatment. Because CKD often progresses gradually, addressing anemia as soon as it develops can significantly improve quality of life and reduce cardiovascular strain.
Nephrology Associates of Northern Illinois and Indiana (NANI) supports kidney health education across these communities, guided by experienced providers including Samuel Agahiu MD, Emmanuelle Gilles MD, Louis Jan MD, and Marc Zelkowitz MD in Bergen; Matthew Anderson MD, Rajiv Gandhi MD, Andrew Kowalski, MPH, FASN MD, and Joanne Wheaton APRN, FNP-C in Berwyn; and Ernest Cabrera MD, John Travis Ludwig MD, Khaleel Sayeed MD, and Ashwin Shetty MD in North Chicago.
Through consistent monitoring, individualized evaluation, and informed care planning, individuals living with CKD can better manage anemia and support long-term health and vitality.
Sources
Babitt JL, Lin HY (2012). Mechanisms of anemia in CKD. Journal of the American Society of Nephrology.
Locatelli F, Bárány P (2013). Anemia management in chronic kidney disease. Nephrology Dialysis Transplantation.
KDIGO Clinical Practice Guideline (2012). Anemia in chronic kidney disease. Kidney International Supplements.
